Health Condition 1: L010- Impetigo
Conditions
Interventions
Intervention1: ozenoxacin cream 1% w/w: drug to be applied 2 times daily for 7 days. For each application minimum one fingertip unit could be used(approximately 0.5g) over affected skin
Control Interv
Sponsors
Department of Pharmacology, IPGMER and SSKM Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patients with clinical diagnosis of impetigo and other uncomplicated skin infections Skin infection Rating Scale(SIRS)score of at least 4 Total affected area should be more than 1 square cm Patients agreeing to come for follow up visit after 7 days
Exclusion criteria
Exclusion criteria: Total affected area exceeding 100 square cm for adults and 2% body surface area for patients aged Concomitant treatment with drugs like antimicrobials, topical steroids and antiseptics, analgesics, immunosuppressants HIV, evidence of immunosuppression, uncontrolled diabetes hypersensitivity to both the drugs Pregnant, lactating patients Signs suggestive of systemic infection like sustained fever, nausea, vomiting, prostration Patients unwilling to give consent Lack of caregiver support Any other condition which in the opinion of investigator is not conducive to inclusion of the patient in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| proportion of subject showing at least 50% reduction in SIRS scoreTimepoint: 7 days | — |
Secondary
| Measure | Time frame |
|---|---|
| safety and tolerability of ozenoxacin in terms of treatment emergent adverse eventsTimepoint: 7 days | — |
Countries
India
Contacts
Public ContactSUKANYA DAS
IPGMER and SSKM Hospital Kolkata
Outcome results
None listed